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Abstract
Hematopoietic stem cells in mammals are known to reside mostly in the bone marrow, but
also transitively passage in small numbers in the blood. Experimental findings have sug-
gested that they exist in a dynamic equilibrium, continuously migrating between these two
compartments. Here we construct an individual-based mathematical model of this process,
which is parametrised using existing empirical findings from mice. This approach allows us
to quantify the amount of migration between the bone marrow niches and the peripheral
blood. We use this model to investigate clonal hematopoiesis, which is a significant risk fac-
tor for hematologic cancers. We also analyse the engraftment of donor stem cells into non-
conditioned and conditioned hosts, quantifying the impact of different treatment scenarios.
The simplicity of the model permits a thorough mathematical analysis, providing deeper
insights into the dynamics of both the model and of the real-world system. We predict the
time taken for mutant clones to expand within a host, as well as chimerism levels that can be
expected following transplantation therapy, and the probability that a preconditioned host is
reconstituted by donor cells.
Author summary
Clonal hematopoiesis—where mature myeloid cells in the blood deriving from a single
stem cell are over-represented—is a major risk factor for overt hematologic malignancies.
To quantify how likely this phenomena is, we combine existing observations with a novel
stochastic model and extensive mathematical analysis. This approach allows us to observe
the hidden dynamics of the hematopoietic system. We conclude that for a clone to be
detectable within the lifetime of a mouse, it requires a selective advantage. I.e. the clonal
expansion cannot be explained by neutral drift alone. Furthermore, we use our model to
describe the dynamics of hematopoiesis after stem cell transplantation. In agreement with
earlier findings, we observe that niche-space saturation decreases engraftment efficiency.
We further discuss the implications of our findings for human hematopoiesis where the
quantity and role of stem cells is frequently debated.
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Introduction
The hematopoietic system has evolved to satisfy the immune, respiratory, and coagulation
demands of the host. A complex division tree provides both amplification of cell numbers
and a variety of differentiated cells with distinct roles in the body [1–3]. In a typical adult
human *1011 terminally differentiated blood cells are produced each day [3–5]. It has been
argued that the division tree prevents the accumulation of mutations, which are inevitable
given the huge number of cell divisions [6–8]. At the base of the tree are hematopoietic stem
cells (HSCs). These have the ability to differentiate into all hematopoietic cell lineages, as well
as the capacity to self-renew [1, 9], although the exact role of HSCs in blood production is still
debated [10, 11].
With an aging population, hematopoietic malignancies are increasingly prevalent [12].
Clonal hematopoiesis—where a lineage derived from a single HSC is overrepresented—has
been identified as a significant risk factor for hematologic cancers [13–15]. To assess the risks
posed to the host we need an understanding of how fast clones are growing, when they initiate,
and if they would subvert physiologic homeostatic control.
The number of HSCs within a mouse is estimated at *0.01% of bone marrow cellularity
[16, 17], which amounts to *10,000 HSCs per host [3, 16, 18, 19]. In humans this number is
subject to debate; limited data has lead to the hypothesis that HSC numbers are conserved
across all mammals [18], but the fraction of ‘active’ HSCs depends on the mass of the organism
[20] (see also Refs [5, 21] for a discussion).
Within an organism, the HSCs predominantly reside in so-called bone marrow niches: spe-
cialised micro-environments that provide optimal conditions for maintenance and regulation
of the HSCs [22, 23]. There are likely a finite number of niches within the bone marrow, and it
is believed that they are not all occupied at the same time [16]. The number of niches is likely
roughly equal to the number of HSCs, and through transplantation experiments in mice it has
been shown that *1% of the niches are unoccupied at any time [16, 24]. A similar number of
HSCs are found in the peripheral blood of the host [16]. These free HSCs are phenotypically
and functionally comparable to (although distinguishable from) bone marrow HSCs [19, 25].
The HSCs have a residence time of minutes in the peripheral blood, and parabiosis experi-
ments (anatomical joining of two individuals) have shown that circulating HSCs can engraft to
the bone marrow [25]. It has also been shown that HSCs can detach from the niches without
cell division taking place [19]. These findings paint a picture of HSCs migrating between the
peripheral blood and the bone marrow niches, maintaining a dynamic equilibrium between
the two compartments.
In this manuscript we construct a model from the above described processes, and we use
this to answer questions about clonally dominant hematopoiesis. We first consider this in
mice, where we use previously reported values to parametrise our model. The model is general
enough that it also captures scenarios of transplantation into both preconditioned (host HSCs
removed) and non-preconditioned hosts: the free niches and the migration between compart-
ments also allows for intravenously injected donor HSCs to attach to the bone marrow niches
and to contribute to hematopoiesis in the host. In the discussion we comment on the implica-
tions of these results for human hematopoiesis.
Materials and methods
Our model, shown schematically in Fig 1, contains two compartments for the HSCs. The bone
marrow (BM) compartment consists in our model of a fixed number, N, of niches. This means
that a maximum of N HSCs can be found there at any time, but generally the number of occu-
pied niches is less than N. The peripheral blood (PB) compartment, however, has no size
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restriction. The number of cells in the PB and BM at a given time are given by s and n,
respectively.
The dynamics are indicated by arrows in Fig 1. Our model is stochastic and individual
based, such that events are chosen randomly and waiting times between events are exponen-
tially distributed. Simulations are performed using the Gillespie stochastic simulation algo-
rithm (SSA) [26]. HSCs in our model are only capable of dividing when attached to a niche;
outside the niche, pre-malignant cells are incapable of proliferating due to the unfavourable
conditions. Upon division, the new daughter HSC enters another niche with probability ρ, or
is ejected into the PB. Here ρ depends on the number of free niches, i.e. ρ = ρ(n), and should
satisfy ρ(N) = 0, such that a daughter cell cannot attach if all niches are occupied. Likewise, the
migration of a HSC from the PB to the BM should depend on the number of empty niches.
We choose the attachment rate as a(N − n)/N per cell. In general, cells can die in both compart-
ments. However, we expect the death rate in the PB, δ, to be higher than the death rate in the
BM, δ0, as the PB is a less favourable environment.
For our initial analysis, we assume there is no death in the BM compartment (δ0 = 0), and
new cells are always ejected into the PB (ρ = 0). These assumptions are relaxed in our detailed
analysis, which can be found in the Supporting Information (S1 Supporting Information).
Fig 1. Compartmental model for a single population of HSCs. The bone marrow (BM) compartment has a fixed total of N niches. At a
given time, n of the niches are occupied, and N − n remain unoccupied. The peripheral blood (PB) compartment has no size restriction, and
at a given time contains s HSCs. A HSC in the BM can detach at rate d and enter the PB, while a cell in the PB can attach to an unoccupied
niche with rate a(N − n)/N. Here (N − n)/N is the fraction of unoccupied niches. HSCs may die in the PB or BM with rates δ and δ0.
Reproduction (symmetric division) of HSCs occurs at rate β. The new daughter cell attaches to an empty niche with probability ρ, otherwise it
is ejected into the PB. Dynamics are concretely described by the reactions in Eq (1).
https://doi.org/10.1371/journal.pcbi.1005803.g001
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A two-compartment model has been considered previously by Roeder and colleagues
[27, 28]. The rate of migration between the compartments is controlled by the number of cells
in each compartment, as well as a cell-intrinsic continuous parameter which increases or
decreases depending on which compartment the cell is in. This parameter also controls the dif-
ferentiation of the HSCs. Further models of HSC dynamics, for example [29–33], have not
considered the migration of cells between compartments. For example, Dingli et al. consider a
constant-size population of HSCs in a homogeneous microenvironment [31, 32]. Competition
between wildtype and malignant cells then follows a Moran process. In our model the BM
compartment size is fixed, but cell numbers can fluctuate.
To initially parametrise our model we consider only one species of HSCs: those which
belong to the host. In a steady-state organism, the number of HSCs in the PB and BM are close
to their equilibrium values, which are labelled as s and n, respectively. These values have
been reported previously in the literature for mice, and are provided in Table 1. Other previ-
ously reported values include the total number of HSC niches N, HSC division rate β, and the
time that cells spend in the PB, which we denote as ℓ. Using these values we can quantify the
remaining model parameters δ, d, and a. These results are discussed in the next section.
When considering a second population of cells, such as a mutant clone or donor cells fol-
lowing transplantation, we may want to impose a selective effect relative to the host HSCs. We
therefore allow the mutant/donor cells to proliferate with rate β2 = (1 + ε)β, where ε represents
the strength of selection. For ε = 0, the mutant/donor cells proliferate at the same rate as the
host HSCs. In the S1 Supporting Information we consider the general scenario of selection act-
ing on all parameters. Our analysis delivers an interesting result: the impact of selection on
clonal expansion is independent of which parameter it acts on (provided δ0 = ρ = 0).
For clonality and chimerism we use the same definition: the fraction of cells within the BM
compartment that are derived from the initial mutant or the donor population of cells. Typi-
cally, experimental measurements of clonality and chimerism use mature cells rather than
HSCs. However, this is beyond the scope of our model so we use HSC fraction as a proxy for
this measurement. We are therefore implicitly assuming that HSC chimerism correlates with
mature cell chimerism. The literature on the role of HSCs in native hematopoiesis is split
[10, 35] (also reviewed in [36]). For the division rate of HSCs in mice we use the value β = 1/39
per day. This is the average division rate of all HSCs within a host deduced from CFSE-staining
experiments [34], but again there is some disagreement in reported values for this quantity
[34, 37, 38]. These differences arise from the interpretation of HSC cell-cycle dynamics.
More concretely, our model consists of four sub-populations: n1 is the number of host or
wildtype cells located in the BM, and s1 is the number of cells of this type in the PB. Likewise,
n2 and s2 are the number of mutant/donor cells in the BM and PB, respectively. The cell num-
bers are affected by the processes indicated in Fig 1 (with δ0 = ρ = 0). The effect of these events
Table 1. Parameter values from empirical murine observations. These are equilibrium values in healthy mice.
Description Parameter Value Reference
Total niches N 10,000 niches [16, 19]
Occupied niches n* 9,900 niches [16, 24]
PB HSCs s* 1–100 cells [19, 25]
Average HSC division rate β 1/39 per day [34]
Time in PB ℓ 1–5 minutes [25]
https://doi.org/10.1371/journal.pcbi.1005803.t001
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and the rate at which they happen are given by the following reactions:
Reproduction : ðni; siÞ   !
bini ðni; si þ 1Þ; ð1aÞ
Death : ðni; siÞ   !
disi ðni; si   1Þ; ð1bÞ
Detachment : ðni; siÞ   !
dini ðni   1; si þ 1Þ; ð1cÞ
Attachment : ðni; siÞ  !
aisiðN  nÞ=N ðni þ 1; si   1Þ; ð1dÞ
where n = ∑i ni, and (N − n)/N is the fraction of unoccupied niches. The corresponding deter-
ministic dynamics are described by the ODEs:
dn1
dt
¼   d1n1 þ a1s1
N   n
N
; ð2aÞ
dn2
dt
¼   d2n2 þ a2s2
N   n
N
; ð2bÞ
ds1
dt
¼ ðd1 þ b1Þn1   d1 þ a1
N   n
N
 
s1; ð2cÞ
ds2
dt
¼ ðd2 þ b2Þn2   d2 þ a2
N   n
N
 
s2: ð2dÞ
Recall we have β1 = β and β2 = (1 + ε)β in the main manuscript, along with δ1 = δ2 = δ,
a1 = a2 = a, and d1 = d2 = d.
Accessibility
A Wolfram Mathematica notebook containing the analytical details can be found at https://
github.com/ashcroftp/clonal-hematopoiesis-2017. This location also contains the Gillespie sto-
chastic simulation code used to generate all data in this manuscript, along with the data files.
Results
Steady-state HSC dynamics in mice
By considering just the cells of the host organism, we can compute the steady state of our sys-
tem from Eq (2), and hence express the model parameters δ, d, and a in terms of the known
quantities displayed in Table 1. These expressions are shown in Table 2, where we also
Table 2. Deduced model parameter values. The parameters δ, d, and a are given here as values per day. The remaining parameters (N, β, n*) are given in
Table 1.
Description Parameter Expression Value (per day)
s*: 1 cell 10 cells 100 cells
ℓ: 1 min 5 mins 1 min 5 mins 1 min 5 mins
Death rate δ bn
s
250 250 25 25 2.5 2.5
Detachment rate d s
‘n   b 0.12 0.0034 1.4 0.27 15 2.9
Attachment rate a 1
‘
  bn

s
  
N
N  n
120,000 3,400 140,000 26,000 140,000 29,000
https://doi.org/10.1371/journal.pcbi.1005803.t002
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enumerate the possible values of these deduced model parameters. Even for the narrow range
of values reported in the literature (Table 1), we find disparate dynamics in our model. At one
extreme, the average time a cell spends in the BM compartment (1/d) can be less than two
hours (for s = 100 cells and ℓ = 1 minute). Thus under these parameters the HSCs migrate
back-and-forth very frequently between the niches and blood, and the flux of cells between
these compartments over a day (s/ℓ) is significantly larger than the population size. In fact,
under these conditions 144,000 HSCs per day leave the marrow and enter the blood. With
slower turnover in the PB compartment (ℓ = 5 minutes, but still s = 100), the average BM resi-
dency time of a single HSC is eight hours, and 28,800 HSCs leave the bone marrow per day. At
the other extreme, if the PB compartment is as small as reported in Ref. [19] (s = 1 cell), then
the residency time of each HSC in the bone marrow niche is between 8 and 290 days (for ℓ = 1
and 5 minutes, respectively). Under these conditions the number of cells entering the PB com-
partment per day is 1,440 and 288, respectively. For an intermediate PB size of s = 10, the BM
residency time is between 17 and 90 hours (for ℓ = 1 and 5 minutes, respectively), and the flux
of cells leaving the BM is a factor ten greater than for s = 1.
Clonal dominance in mice
Clonal dominance occurs when a single HSC generates a mature lineage which outweighs the
lineages of other HSCs, or where one clone of HSCs outnumbers the others. The definition of
when a clone is dominant is not entirely conclusive. Previous studies of human malignancies
have used a variant allele frequency of 2%, corresponding to a clone that represents 4% of the
population [39, 40]. For completeness we investigate clonality ranges from 0.1% to 100%.
In the context of disease, this clone usually carries specific mutations which may confer a
selective advantage over the wildtype cells in a defined cellular compartment. The de novo
emergence of such a mutant occurs following a reproduction event. Therefore, in our model
with ρ = 0, after the mutant cell is generated it is located in the PB compartment, and for the
clone to expand it must first migrate back to the BM. This initial phase of the dynamics is con-
sidered in general in the next section of transplant dynamics, where a positive number S of
mutant/donor cells are placed in the PB. We find (as shown in the S1 Supporting Information)
that the expected number of these cells that attach to the BM after this initial dynamical phase
is
n2 ¼
aðN   nÞ=N
dþ aðN   nÞ=N
S ¼ 1  
b‘n
s
 
S: ð3Þ
We then apply a fast-variable elimination technique to calculate how long it takes for this
clone to expand within the host [41, 42]. This procedure reduces the dimensionality of our sys-
tem, and makes it analytically tractable. A full description of the analysis can be found in the
S1 Supporting Information, but we outline the main steps and results of this procedure below.
We first move from the master equation—the exact probabilistic description of the stochas-
tic dynamics—to a set of four stochastic differential equations (SDEs) for each of the variables
via an expansion in powers of the large parameter N [43]. We then use the projection method
of Constable et al. [41, 42] to reduce this system to a single SDE describing the relative size of
the clone. This projection relies on the weak-selection assumption, i.e. 0 ε 1. The stan-
dard results of Brownian motion are then applied to obtain the statistics of the clone’s expan-
sion. In particular, the probability that the mutant/donor HSCs reach a fraction 0< σ 1 of
the occupied BM niches is given by
ðz0; sÞ ¼
1   e  Lz0
1   e  Lsx
; ð4Þ
Clonal dominance in hematopoietic stem cells
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where z0 is the initial clone size can be found explicitly from Eq (3), such that z0 = n2/N. We
also have ξ = n/N, and Λ is a constant describing the strength of deterministic drift relative to
stochastic diffusion. Concretely, we have
L ¼ εN
dbþ ddþ bd
ðd þ bÞd
¼ εN 1þ
s
n
  b‘
 
: ð5Þ
The mean time for the clone to expand to size σ (i.e. the mean conditional time) is written as
Tξ(z0, σ) = θ(z0, σ)/ϕ(z0, σ), where θ(z0, σ) is given by the solution of
@
2
yðz0; sÞ
@z2
0
þ L
@yðz0; sÞ
@z0
¼  
N
B
ðz0; sÞ
z0ðx   z0Þ
; yð0Þ ¼ yðsxÞ ¼ 0: ð6Þ
Here B is another constant describing the magnitude of the diffusion, and is given by
B ¼
dðd þ bÞbd2
xðdbþ ddþ bdÞ2
¼
bN
s
s
n
  b‘
1þ
s
n
  b‘
 2 : ð7Þ
Although a general closed-form solution to Eq (6) is possible, it is too long to display here.
Instead we use an algebraic software package to solve the second-order differential equation. A
similar expression to Eq (6) can be obtained for the second moment of the fixation time, as
shown in [44] and repeated in the S1 Supporting Information.
The first scenario we consider is the expansion of a neutral clone (ε = 0); i.e. how likely is it
that a single cell expands into a detectable clone in the absence of selection? It is known that
the time to fixation of a neutral clone in a fixed-size population grows linearly in the system
size [45]. Interestingly and importantly, in intestinal crypts this fixation is seen frequently
because N ¼ Oð10Þ [46]. In the hematopoietic system, however, it likely takes considerably
longer than this due to the relatively large number of stem cells. Solving Eq (6) with ε = 0 gives
the mean conditional expansion time as
Txðz0; sÞ ¼
N
B
x   z0
z0
log
x
x   z0
 
þ
1   s
s
log ð1   sÞ
 
: ð8Þ
From this solution we find that it takes, on average, 5–45 years for a neutral clone to reach 1%
clonality (*100 HSCs). Expanding to larger sizes takes considerably longer, as highlighted in
Fig 2. Therefore, clonal hematopoiesis in mice is unlikely to result from neutral clonal expan-
sion; for a clone to expand within the lifetime of a mouse it must have a selective advantage.
Neutral results for human systems are considered in the discussion.
When the mutant clone has an advantage, there is always some selective force promoting
this cell type. Therefore the probability of such a clone expanding is higher than the neutral
case, as seen from Eq (4). In Fig 2 we illustrate the time taken for a single mutant HSC to reach
specified levels of clonal dominance for different selective advantages. Advantageous clones
(β2/β> 1) initially grow exponentially in time [Fig 2(a)], and are much faster than neutral
expansion (β2/β = 1). These clones can reach levels of up to 90% relatively quickly, however
replacing the final few host cells takes much longer. The advantage that a mutant clone must
have if it is to represent a certain fraction of the population in a given period of time can be
found from Fig 2(b). For a single mutant to completely take over in two years, it requires a fold
reproductive advantage of β2/β 2 [dashed lines in Fig 2(b)]. This means that the cells in this
clone are dividing at least twice as fast as the wildtype host cells. To achieve 1% clonality in this
timeframe, the advantage only has to be β2/β 1.2. For the clone to expand in shorter time
Clonal dominance in hematopoietic stem cells
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intervals, a substantially larger selective advantage is required. For example, 100% clonality in
six months from emergence of the mutant requires β2/β 5.5, i.e. the dominant clone needs
to divide more than five times faster than the wildtype counterparts.
As shown in the S1 Supporting Information, Eqs (4) and (6) are equivalent to the results
obtained from a two-species Moran process. This suggests the two-compartment structure is
not necessary to capture the behaviour of clonal dominance. However, the consideration of
multiple compartments is required to understand transplantation dynamics, as covered in the
next section.
Transplant success in mice
We now turn our attention to the scenario of HSC transplantation. As previously mentioned
this situation is analogous to the disease spread case, with the exception that the initial ‘dose’ of
HSCs can be larger than one. We first consider the case of a non-preconditioned host. We
then move onto transplantation in preconditioned hosts, where all host cells have been
removed.
Engraftment in a non-preconditioned host. Multiple experiments have tested the
hypothesis that donor HSCs can engraft into a host which has not been pretreated to remove
some or all of the host organism’s HSCs [16, 19, 34, 47–53]. These studies have found that
engraftment can be successful; following repeated transplantations mice display a chimerism
with up to 40% of the HSCs deriving from the donor [48–50].
In this scenario we start with a healthy host organism and inject a dose of S donor HSCs
into the PB compartment, in line with the experimental protocols mentioned above. These
donor cells can be neutral, or may have a selective (dis)advantage. Injecting neutral cells
reflects the in vivo experiments described above, while advantageous cells can be used to
improve the chances of eliminating the host cells. Transplanting disadvantageous cells would
reflect the introduction of ‘normal’ HSCs into an already diseased host carrying advantageous
cells. We do not consider this scenario further here, as the diseased cells are highly unlikely to
be replaced without host preconditioning.
Fig 2. Time taken for a clone initiated from a single HSC to expand under different levels of selection. (a) Time taken for a mutant
clone to expand as a function of the level of clonality reached, with colour indicating the selective effect of the mutant. (b) Time taken for a
mutant clone to expand as a function of the selective effect, with colour indicating different levels of clonality. Symbols are results from 103
simulations of the full model (with associated standard deviations), and solid lines are predictions from Eq (6). Shaded regions are the
predicted standard deviations, using the formula presented in the S1 Supporting Information. Here ℓ = 3 minutes, s* = 100, and the
remaining parameters are as in Table 1.
https://doi.org/10.1371/journal.pcbi.1005803.g002
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We can separate the engraftment dynamics of these donor cells into two different regimes:
i) the initial relaxation to a steady state where the total number of HSCs is stable, and ii) long-
time dynamics eventually leading to the extinction of either the host or donor HSCs. We focus
on these regimes separately. Upon the initial injection of the donor HSCs, the PB compart-
ment contains more cells than the equilibrium value s. This leads to a net flux of cells attach-
ing to the unoccupied niches in the BM until the population relaxes to its equilibrium size.
Once the equilibrium is reached, the initial dynamics end, and the long-term noise-driven
dynamics take over (discussed below). The challenge for this first part is to determine how
many of the donor HSCs have attached to the BM at the end of the initial dynamics.
We identify two distinct behaviours which occur under low and high doses of donor HSCs.
If the dose is small (S⪡N   n), then the number of donor HSCs that attach to the BM is
given by Eq (3), and is proportional to the dose size S. To obtain this result we have assumed
that the number of occupied niches remains constant, such that each donor cell has the same
chance of finding an empty niche. However, if the dose of donor HSCs is large enough then all
niches become occupied and the BM compartment is saturated; attachment to the BM can
only occur following a detachment. Using this assumption, the initial dynamics can then be
described by the linear ODEs
dn2
dt
¼   dn2 þ
dN
sðtÞ
s2; ð9aÞ
ds2
dt
¼ ðbþ dÞn2   dþ
dN
sðtÞ
 
s2; ð9bÞ
where s(t), the total number of cells in the PB compartment, is found from _s ¼ bN   ds. A
derivation of Eq (9) can be found in the S1 Supporting Information.
The predicted chimerism, and the accuracy of these predictions, at the end of the initial
phase are shown in Fig 3. The efficiency of donor cell engraftment decreases in the large-dose
Fig 3. Initial chimerism of neutral donor cells in a healthy, non-preconditioned host. Upper panels depict the level of donor chimerism
shortly after a dose of neutral donor cells, S, is injected into the host. Symbols are from numerical integration of Eq (2). The small-dose
regime is described by Eq (3) (solid lines for S < 103), and the large-dose regime is described by Eq (9) (solid lines for S > 102). Lower
panels show the accuracy of these approximations when compared to the numerical integration of Eq (2). This error takes the form (approx.
− exact)/exact. (a) s* = 10, and (b) s* = 100. The lifetime in the PB, ℓ, is measured in minutes. Remaining parameters are as in Table 1.
https://doi.org/10.1371/journal.pcbi.1005803.g003
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regime (S > N   n). This is simply because the niche-space is saturated, so HSCs spend lon-
ger in the blood and are more likely to perish. If the lifetime in the PB (ℓ) is short, then we have
more frequent migration between compartments, as highlighted in Table 2. Hence smaller ℓ
leads to higher chimerism. The approximation from Eq (9) becomes increasingly accurate for
larger doses. The two approximations break down at the cross-over region between small and
large doses. In this regime the number of occupied niches does not reach a stable value.
If the donor cells have a selective (dis)advantage, then the deterministic dynamics predict
the eventual extinction of either the host or donor cells. However, the selective effect is usually
small and only acts on a longer timescale. Therefore the initial dynamics are largely unaffected
by selection, and we assume neutral donor cell properties when we model the initial dynamics.
The inefficiency of large doses can be overcome by administering multiple small doses over
a long period. In this way we prevent the niches from becoming saturated and fewer donor
cells die in the PB. Hence we should be able to obtain a higher level of engraftment when com-
pared to a single-bolus injection of the same total number of donor HSCs. These effects have
been tested experimentally [19, 48–50]. Parabiosis experiments are also an extreme example of
this; they represent a continuous supply of donor cells [25]. As shown in Fig 4, our model cap-
tures the same qualitative behaviour as reported in the experiments: Multiple doses lead to
higher levels of chimerism at the end of the initial phase of dynamics. This effect is highlighted
more when the total dose size is large. Using our analysis we know how efficient each dose is,
and what levels of chimerism can be achieved. Hence our model can be used to optimise dos-
ing schedules such that they are maximally efficient.
We note here that engraftment efficiency is only important when donor cells are rare and
there is no danger to life. This is the case, for example, in experimental protocols when track-
ing small numbers of cells. It makes sense to here use the multiple dosing strategy. Transplan-
tation following preconditioning, however, provides a more viable approach to disease
Fig 4. Number of donor HSCs attaching to the BM of a non-preconditioned host after a single dose (dashed lines) or seven daily
doses (solid lines). Both treatments use the same total number, S, of donor HSCs. Trajectories are from numerical integration of the ODEs
Eq (2). Here we have ℓ = 3 minutes, s* = 100, and the remaining parameters are as in Table 1.
https://doi.org/10.1371/journal.pcbi.1005803.g004
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treatment where patient survival needs to be maximised. In this case the dose size should be
increased, but it should be considered that there are diminishing returns in engraftment when
the dose size is large enough to saturate all open niches. This dose size can be read from Fig 3.
The long-term dynamics are handled in the same way as the clonal dominance results
above; we use Eqs (4) and (6) to show how the number of donor cells injected into the PB
affects the probability that they expand (as opposed to die out), and the time it takes for the
host cells to be completely displaced. One key result is that a dose of just eight HSCs with an
advantage of β2/β = 1.1 has over 50% chance to fixate in the host. However, the time for this to
happen is *16 years. With a reproductive advantage of β2/β = 1.5 the success rate is *95% for
the same dose, and the time taken now falls to *4 years. Further results are found in the S1
Supporting Information.
Engraftment in a preconditioned host. HSC transplantation procedures are often pre-
ceded by treatment or irradiation of the host—referred to as host preconditioning. This greatly
reduces the number of host HSCs in the BM compartment. For this section we assume com-
plete conditioning such that no host HSCs remain, i.e. myeloablative conditioning. Following
the pre-treatment, a dose of donor HSCs of size S is injected into the PB compartment. We
then want to know the probability that these cells reconstitute the organism’s hematopoietic
system. For this section we assume that donor HSCs have identical properties to the wildtype
cells (i.e. no selection). We further assume that all donor HSCs have the potential to reconsti-
tute the hematopoietic system in the long-term—in experiments this is not always the case as
not all cells which are sorted as phenotypic HSCs (as defined by surface markers) are func-
tional, reconstituting HSCs (see e.g. [54]). Because of this assumption, we only show results for
the injection of a single donor HSC into the conditioned host (S ¼ 1). Higher doses lead to a
greater probability of reconstitution. A further assumption is, that the host maintains (or is
provided with) enough mature blood cells during the reconstitution period to sustain life.
We consider two approaches for estimating the probability of hematopoietic reconstitution.
As a first-order approximation, the probability that a single HSC in the PB compartment
dies is ψ = δ/(δ + a). Here we have assumed that all niches are unoccupied, such that the attach-
ment rate per cell is a(N − 0)/N = a. For a dose of size S, the reconstitution probability is
φ ¼ 1   cS . Hence we have
φ ¼ 1  
d
dþ a
 S
: ð10Þ
This prediction, Eq (10), is shown as dotted lines in Fig 5, which, however, does not agree with
results from the model. The second approach considers all possible combinations of detach-
ments and reattachments, as well as reproduction events. This leads to a reconstitution proba-
bility, given a dose of S donor cells, of
φ ¼ 1  
d
dþ a
d þ b
b
 S
; ð11Þ
which is derived in the S1 Supporting Information. This result, Eq (11), is shown as solid lines
in Fig 5, and is in excellent agreement with the reconstitution probability observed in simula-
tions. From these results we can conclude that, in our model, HSCs migrate multiple times
between the PB and BM before they establish a sustainable population. It is also the case that in
this model a single donor HSC is sufficient to repopulate a conditioned host in *90–99% of
cases across all the parameter ranges reported in Table 1.
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Discussion
We have introduced a mathematical model that describes the back-and-forth migration of
hematopoietic stem cells between the blood and bone marrow within a host. This is motivated
by the literature of HSC dynamics in mice. The complexity of the model has been kept to a
minimum to allow us to parametrise it based on empirical results. The model is also analyti-
cally tractable, permitting a more thorough understanding of the dynamics and outcomes. For
example, on long timescales we find the that the two-compartment model is equivalent to the
well-studied Moran model. Meanwhile, analysis of the reconstitution of a preconditioned
mouse shows that in our model HSCs migrate multiple times between the BM and PB com-
partments before establishing a sustainable population.
Given these dynamics we first investigate clonal dominance, where a clone originating
from a single mutant cell expands in the HSC population. In mice we find that a selective
advantage is required if the clone is to be detected within a lifetime: A clone starting from a
single cell with a reproduction rate 50% higher than the wildtype can expand to 1% clonality in
one year. A cell dividing twice as fast as the wildtype reaches > 10% clonality in the same time-
frame. Such division rates can be reached by MPN-initiating HSCs [55]. The requirement of a
Fig 5. Probability of reconstitution from a single donor HSC which is injected into a preconditioned host. Symbols are results from
105 simulations of the stochastic model. For efficiency we ran the simulations until the population reached either 0 (extinction) or 100
(reconstitution), and we assume no further extinction events occur once this upper limit has been reached. Dotted lines are the ‘first-order’
prediction of Eq (10). Solid lines are the predictions of Eq (11) which account for detachments, reattachments, and reproduction events.
Remaining parameters are as in Table 1.
https://doi.org/10.1371/journal.pcbi.1005803.g005
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selective advantage agrees with the clinical literature where, for example, mutants are known
to enjoy a growth advantage under inflammatory conditions [56, 57].
The model also captures the scenario of stem cell transplantation. Engraftment into a non-
preconditioned host is analogous to clonal dominance, except that the clone is initiated by
multiple donor cells. For small doses of donor HSCs, the number of cells that attach to the BM
is directly proportional to the size of the dose. For larger doses the BM niches are saturated,
leading to lower engraftment efficiency. Donor chimerism can be improved by injecting the
host with multiple small doses, as opposed to a large single-bolus dose of the same size. This
agrees with results that have been reported in the empirical literature [19, 48–50]. Following
preconditioning of a mouse to remove all host cells, we find that a single donor HSC is suffi-
cient to repopulate a host in *90–99% of cases. This result rests on the assumption that the
donor stem cell was, in fact, a long-term reconstituting HSC, which may not be the case in
experimental setups.
In the S1 Supporting Information we consider the effects of death occurring in the BM
niche (δ0 6¼ 0), and the direct attachment of a new daughter cell to the bone marrow niche
(ρ 6¼ 0). We find that death in the niche increases the migration rate of cells between the PB
and BM compartments, which can greatly reduce the attachment success of the low-frequency
mutant/donor cells. However, the direct attachment of daughter cells to the niche has no effect
on the initial attachment of donor/mutant cells, and on the level of chimerism achieved in the
initial phase of the dynamics.
Broadening the scope of our investigation, clonality of the hematopoietic system is a major
concern for human health [13–15, 39]. Clinical studies have shown that 10% of people over 65
years of age display clonality, yet 42% of those developing hematologic cancer displayed clonal-
ity prior to diagnosis [13]. Our model, and the subsequent analysis, can be applied to this sce-
nario. However, the number of HSCs in man is debated, with estimates of *400 [20, 58],
Oð104Þ [18], or Oð107Þ [5]. Estimates as high as Oð109Þ can also be obtained by combining
the total number of nucleated bone marrow cells [59] with stem cell fraction measurements
[1, 60, 61]. In Fig 6 we summarise how neutral and advantageous clones starting from a single
HSC expand in human hematopoietic systems. We find that 4% clonality [39, 40] can be
achieved in a short period of time for even neutral clones [Fig 6(a)]. If the human HSC pool is
Oð103Þ or smaller, we would expect clonal hematopoiesis and the associated malignancies to
be highly abundant in the population, perhaps more-so than they currently are [13–15, 39].
On the other hand, for a system size of N = 106 it takes thousands of years for a single neutral
HSC to expand to detectable levels, making neutral expansion extremely unlikely to result in
clonal hematopoiesis. Therefore, for clonal hematopoiesis to occur in a pool of this size or
larger [5] the mutants would require a significant fitness advantage over the wildtype HSCs.
We also consider a range of parameters, and even relax the α = % = 0 condition, in S1 and S2
Figs. We find no significant differences in the predictions of our model.
Limitations
Our model has been kept to a minimal level of biological detail to allow for parametrisation
from experimental results. This has the added benefit of analytic tractability. The model is con-
structed under steady-state conditions, which is the case for neutral clonal expansion. How-
ever, in the case of donor-cell transplantation following myeloablative preconditioning, we are
no longer in a steady state. Here we expect some regulatory mechanisms to affect the HSC
dynamics, including a faster reproductive rate and a reduced probability of cells detaching
from the niche. There are also possibilities for mutants to exploit or evade the homeostatic
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mechanisms [63]. Different mechanisms of stem cell control have recenty been considered for
hematopoietic cells [64], as well as in colonic crypts [65].
The steady state assumption is also unable to capture the different dynamics associated with
ageing. For example, in young individuals the hematopoietic system is undergoing expansion.
In our model there is no distinction between young and old systems. In S3 Fig we demonstrate
the impact of a (logistically) growing number of niches. Such growth means clonal hematopoi-
esis is likely to be detected earlier, and therefore would increase our lower bound estimate on
the number of HSCs in man. Telomere-length distributions have been used to infer the HSC
dynamics from adolescence to adulthood, and have suggested a slowing down of HSC divi-
sions as life progresses [66]. Faster dynamics in early life would lead to a higher incidence
among young people, which again increases our lower bound estimate.
It is also not entirely clear how to extrapolate the parameters from the reported mouse data
to a human system. Here we have taken the simplest approach and appropriately scaled the
unknown parameters. However, hematopietic behaviour may differ between species. For
example, results of HSC transplantation following myeloablative therapy in non-human pri-
mates have shown that clones of hematopoietic cells persist for many years [67, 68]. This could
Fig 6. Time taken until a clone initiated from a single cell represents 4% [39, 40] of the human HSC pool, as a function of the total
number of niches in the system. Colours represent the selective advantage of the invading clone. Lines are given by the solution of Eq (6),
and shaded regions represent the calculated standard deviation (details in the S1 Supporting Information). Remaining parameters are β = 1/
40 week−1 [62], ℓ = 60 minutes, s* = 0.01N, and n* = 0.99N. Here ℓ, s*, and n* are extrapolated from the murine data, where ℓhuman
10ℓmouse, which follows the same scaling as the HSC division rate, β. Further parameter combinations are shown in S1 and S2 Figs.
References refer only to the source of parameters; no part of this figure has been reproduced from previous works.
https://doi.org/10.1371/journal.pcbi.1005803.g006
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be due to single HSCs remaining attached to the niche and over-contributing to the hemato-
poietic system, or due to clonal expansion of the HSCs to large enough numbers such that a
contributing fraction will always be found in the BM. Both of these mechanisms are features of
our model: the time a cell spends in the BM is much longer than the time in the PB and can be
increased further by tuning the model parameters, namely by decreasing s or increasing ℓ.
Changes to these parameters seems to have little effect on our predictions of clonal expansion,
as shown in S1 and S2 Figs. Clonal extinctions are also a feature of our work, and have been
identified in non-human primates [68].
A more general point to discuss is the role of hematopoietic stem cells in blood production.
In our model we are only considering HSC dynamics, however it has been proposed that
downstream progenitor cells are responsible for maintaining hematopoiesis [11] in mice.
Hence, myeloid clonality would also be determined by the behaviour of these progenitor cells.
On the other hand, an independent study found that HSCs are driving multi-lineage hemato-
poiesis [10], suggesting we are correct in our approach. Again we also expect there to be varia-
tion between species in this balance of HSC/progenitor activity. With little quantitative
information available, we have assumed that HSCs are the driving force of steady-state hema-
topoiesis across mice and humans.
Conclusion
In conclusion, this simple mathematical model encompasses multiple HSC-engraftment sce-
narios and qualitatively captures empirically observed effects. The mathematical calculations
provide insight into how the dynamics of the model unfold. The analytical results, which we
have verified against stochastic simulations, allow us to easily investigate how parameter varia-
tion affects the outcome. We now hope to extend this analysis, incorporating further effects of
disease and combining this model with the differentiation tree of hematopoietic cells.
Supporting information
S1 Supporting Information. Supporting mathematical details. Contains detailed derivations
of all equations presented in the manuscript, including the details of the projection method.
The analysis is carried out for unrestricted parameters, including selective effects on all param-
eters and permitting death in the BM space, as well as direct attachment of new daughter cells
to the niche.
(PDF)
S1 Fig. Clonality in man: More parameter combinations and death within niches. Time
taken until a clone initiated from a single cell represents 4% [39, 40] of the human HSC pool,
as a function of the total number of niches in the system. Colours represent the selective
advantage of the invading clone. Solid lines correspond to death only within the niches (α = 0),
while dashed lines represent equal death rates in both compartments (α = 1; see S1 Supporting
Information for details). Lines are generated using mathematical formulae in the S1 Support-
ing Information. Remaining parameters are β = 1/40 week−1 [62], n = 0.99N, and % = 0. Some
predictions are missing when d 0 and/or a 0; these parameter regimes are incompatible
with our model.
(TIFF)
S2 Fig. Clonality in man: More parameter combinations and reproduction into BM. Time
taken until a clone initiated from a single cell represents 4% [39, 40] of the human HSC pool,
as a function of the total number of niches in the system. Colours represent the selective
advantage of the invading clone. Solid lines correspond to the daughter cell entering the PB
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compartment after reproduction (% = 0), while dashed lines represent daughter cells remaining
in the BM (% = 1; see S1 Supporting Information for details). Lines are generated using mathe-
matical formulae in the S1 Supporting Information. Remaining parameters are β = 1/40
week−1 [62], n = 0.99N, and α = 0. Some predictions are missing when d 0 and/or a 0;
these parameter regimes are incompatible with our model.
(TIFF)
S3 Fig. Predicted and simulated incidence curves of clonal hematopoiesis in man: Constant
size and under growth. The cumulative probability density function (CDF) of times to reach
4% clonality [39, 40] when starting from a single neutral mutant in a normal host. Shaded
regions are incidence curves from simulations using either a constant niche count of N = 104,
or a logistically growing number of niches with _N  rNð1   N=KÞ, where K = 104, r = 0.3 per
year, and N(0) = K/20. These parameters represent a maturation period of *20 years to reach
N K. Lines are predicted incidence curves which assume normally-distributed times to clon-
ality, using the mean and variance formulae as described in the S1 Supporting Information,
and constant population size as indicated in the legend (minimum and maximum number of
niches). Remaining parameters are β = 1/40 week−1 [62], n = 0.99N, s = 0.01N, and ℓ = 60
minutes. Finally, we only consider here the conditional incidence time, which have been nor-
malised by the fixation probability. This probability is 20 times larger for the neutral mutant in
the growing model when compared to the fixed number of niches.
(TIFF)
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